Loading
Cancer Research and Treatments · Journal article
Russian Journal of Bioorganic Chemistry · September 4, 2026
A consensus or society position rather than new primary data.
This is a narrative review article that synthesizes current knowledge on antimicrobial resistance mechanisms and emerging treatment strategies for multidrug-resistant bacterial infections. It does not report original clinical trial data, experimental results, or comparative effectiveness evidence, but rather provides expert perspective on the state of the field and promising therapeutic directions.
Narrative review.
Global antimicrobial resistance poses a formidable threat to public health and renders conventional strategies less efficacious Bacterial evolution and phenotypic adaptation progressively exacerbate treatment-associated adverse effects Synergistic combinations and novel strategies are needed to combat multidrug-resistant pathogens
Bacterial evolution and phenotypic adaptation progressively exacerbate treatment-associated adverse effects
Clinicians should recognize this as a synthesis of expert opinion and existing literature on resistance mechanisms and therapeutic innovation rather than as evidence from controlled trials. It may serve to orient practice around emerging resistance challenges and identify promising research directions, but does not provide comparative effectiveness data to guide specific treatment choices.
This is a narrative review synthesizing scientific literature on antimicrobial resistance mechanisms and treatment approaches, offering expert perspective rather than reporting original trial data or clinical evidence.
As stated by the source record.
Clinicians should recognize this as a synthesis of expert opinion and existing literature on resistance mechanisms and therapeutic innovation rather than as evidence from controlled trials. It may serve to orient practice around emerging resistance challenges and identify promising research directions, but does not provide comparative effectiveness data to guide specific treatment choices.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
The global expansion of antimicrobial resistance poses a formidable threat to public health. Ongoing bacterial evolution and phenotypic adaptation progressively render conventional antimicrobial strategies resource-intensive and less efficacious, while concurrently exacerbating treatment-associated adverse effects. Consequently, there is an imperative demand to refine existing therapeutic modalities, implement synergistic combinations, and pioneer fundamentally novel strategies to combat infections precipitated by multidrug-resistant pathogens. This review delineates the primary molecular mechanisms governing bacterial resistance and underscores the clinical impact of key infectious diseases. The cornerstone of this work lies in a comprehensive analysis of both canonical and innovative paradigms in antibacterial therapy. By synthesizing state-of-the-art scientific data, this paper provides a definitive perspective on the most promising frontiers in infectious disease management.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.